Bcr-Abl
Bcl-Abl is a constitutively activated chimeric tyrosine kinase which is the genetic abnormality expressed in patient with CML (chronic myeloid leukemia).
Products for Bcr-Abl
- Cat.No. Product Name Information
-
BCC3988
CHMFL-ABL-053BCR-ABL inhibitor
-
BCC4389
GZD824Bcr-Abl inhibitor,novel orally bioavailable
-
BCC6529
GNF-7Ack1 and GCK inhibitor; inhibits RAS signaling
-
BCC8058
ON 146040
